Century Therapeutics vs Kymera Therapeutics
IPSC and KYMR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IPSC and KYMR compare
Kymera Therapeutics is the larger company, worth 40 times as much as Century Therapeutics ($10.5B against $266M).
Kymera Therapeutics scores higher on the StockData Score (9 against 8 for Century Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IPSC | KYMR |
|---|---|---|
| Size and price | ||
| Market cap | $266M | $10.5B |
| Share price | $1.47 | $126.63 |
| Change, 1 year | 155% | 111% |
| Change, 5 years | −93.7% | 95.0% |
| Beta (5Y) | 1.41 | 1.97 |
| Employees | 78 | 238 |
| StockData Score | ||
| Total score | 8 | 9 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 1 |
| Performance score | 1 | 2 (better) |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 103× |
| P/B | 1.1× (better) | 6.5× |
| FCF yield | −33.1% | −2.7% (better) |
| Fair value | – | $38.85 |
| Margin of safety | – | −226% |
| Growth | ||
| Revenue growth (TTM) | – | 134% |
| Revenue growth, 5Y average | – | 2.9% |
| Profitability | ||
| Gross margin | – | 0.00% |
| Operating margin | – | −396% |
| Net margin | – | −342% |
| FCF margin | – | −283% |
| Return on equity | −49.7% | −27.3% (better) |
| Return on invested capital | −113% | −59.0% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 8.28 | 11.13 (better) |
| Altman Z-score | −2.10 | 40.23 (better) |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Buyback yield | −0.23% | – |
| Shareholder yield | −0.23% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 87.3% | 117% |
| Held by insiders | 3.8% | 39.4% |
| Insider net buying, 12 months | $10.9K (better) | −$297M |
| Short interest, % of float | 16.8% | 19.7% |
Go deeper
- IPSC stock overview
- IPSC income statement
- IPSC valuation and score
- KYMR stock overview
- KYMR income statement
- KYMR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.